Skip to content
lifestyle.massnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Satellos Bioscience Inc.
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
June 29, 2026
Satellos to Present Clinical Program Updates at ICNMD 2026
June 25, 2026
Satellos Bioscience Announces Results of Annual Meeting of Shareholders
June 17, 2026
Satellos to Participate in Upcoming Investor Conferences
May 27, 2026
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress
May 15, 2026
←
Previous Page
1
2